SGO Journal Club On-Demand: The ABCs of ADCs

Tune in to the Journal Club's Fall 2022 installment, The ABCs of ADCs, where panelists discuss antibody drug conjugates for gynecologic cancers including tisotumab vetodin, mirvetuximab soravtansine, as well as strategies in managing side effects and toxicities.

Speakers:
Erin Hickey, PharmD, BCOP
Ursula Matulonis, MD
Roisin O'Cearbhaill, MD
 
Moderators:
Lee-May Chen, MD
Jovana Martin, MD

 

Course summary
Course opens: 
11/09/2022
Course expires: 
11/10/2030
Cost:
$0.00
Rating: 
0

Price

Cost:
$0.00
Please login or register to take this course.